The role of hepatic stellate cells in development and progression of hepatocellular carcinoma

Chen QiMing; Chen QingFeng

doi:10.3969/j.issn.1001-5256.2014.03.023

Issue 3

Mar. 2014

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2014 > 30(3): 285-288

PDF( 1228 KB)

The role of hepatic stellate cells in development and progression of hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2014.03.023

Published Date: 2014-03-20

Abstract

Abstract

A growing body of literature highlights the cross- talk between tumor cells and the surrounding peritumoral stroma as a key modulator in the development, invasion, and metastasis of hepatocellular carcinoma ( HCC) . Hepatic stellate cells ( HSC) , an important component in the microenvironment of HCC, play an important role in the development and progression of “inflammation- fibrosis / cirrhosis-tumor”. The origin and activation of HSC, as well as the effects of HSC and their cytokines on the immune response in the proliferation, metastasis, and invasion of HCC, are reviewed. It is thought that HSC are not only a“hotbed”for tumor growth, but also help resist the tumor tracing and elimination mechanism of the immune system. Therefore, it is worth developing treatments targeting the tumor microenvironment when the single anti- cancer therapy is ineffective.
- carcinoma, hepatocellular,
- adipocytes,
- cytokines,
- review

FullText(HTML)

References(36)

References

[1]YANG X, LI YJ.Effect of spleen-strengthening and qi-benefiting therapy on immune microenvironment of primary liver cancer[J].Jilin J Tradit Chin Med, 2013, 33 (1) :9-11. (in Chinese) 杨欣, 李涌健.健脾益气法对原发性肝癌免疫微环境影响的研究[J].吉林中医药, 2013, 33 (1) :9-11.

[2]FAOUZI S, LE BAIL B, NEAUD V, et al.Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma:an in vivo and in vitro study[J].J Hepatol, 1999, 30 (2) :275-284.

[3]CHENG ZY, PENG JC, LYU YH.Research advances in effect of epithelial-mesenchymal trcmsition on liver fibrosis[J].Chin J Clin Pharmacol Ther, 2013, 18 (8) :929-936. (in Chinese) 成志云, 彭俊纯, 吕颖慧.上皮一间充质转化对肝纤维化作用的研究进展[J].中国临床药理学与治疗学, 2013, 18 (8) :929-936.

[4]FAOUZI S, LEPREUX S, BEDIN C, et al.Activation of cultured rat hepatic stellate cells by tumoral hepatocytes[J].Lab Invest, 1999, 79 (4) :485-493.

[5]WANG W, GUAN Y, YANG ML, et al.Association between activation of hepatic stellate cells and development and metastasis of hepatocellular carcinoma[J].Chin J Clin Exp Pathol, 2007, 23 (4) :492-494. (in Chinese) 王伟, 官阳, 杨木兰, 等.活化肝星状细胞与肝细胞肝癌发生及转移的相关性[J].临床与实验病理学杂志, 2007, 23 (4) :492-494.

[6]XIA Y, CHEN R, SONG Z, et al.Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum[J].J Cancer Res Clin Oncol, 2010, 136 (2) :309-321.

[7]SANCHO-BRU P, JUEZ E, MORENO M, et al.Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells[J].Liver Int, 2010, 30 (1) :31-41.

[8]ENZAN H, HIMENO H, IWAMURA S, et al.Alpha-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma[J].Hepatology, 1994, 19 (4) :895-903.

[9]ZHOU L, WANG Z, GAO Y, et al.Stimulation of hepatoma cell invasiveness and metastatic potential by proteins secreted from irradiated nonparenchymal cells[J].Int J Radiat Oncol Biol Phys, 2012, 84 (3) :822-828.

[10]AMANN T, BATAILLE F, SPRUSS T, et al.Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma[J].Cancer Sci, 2009, 100 (4) :646-653.

[11]ZHAO W, ZHANG L, YIN Z, et al.Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice[J].Int J Cancer, 2011, 129 (11) :2651-2661.

[12]JIA YL, SHI L, ZHOU JN, et al.Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis[J].Hepatology, 2011, 54 (5) :1808-1818.

[13]CAMPBELL J, HUGHES S, GILBERTSON D, et al.Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma[J].Proc Natl Acad Sci U S A, 2005, 102 (9) :3389-3394.

[14]OTRANTO M, SARRAZY V, BONTF, et al.The role of the myofibroblast in tumor stroma remodeling[J].Cell Adh Migr, 2012, 6 (3) :203-219.

[15]WANG L, PARK H, CHHIM S, et al.A novel monoclonal antibody to fibroblast growth factor 2 effectively inhibits growth of hepatocellular carcinoma xenografts[J].Mol Cancer Ther, 2012, 11 (4) :864-872.

[16]WANG ZM.The study on the role of rat hepatic stellate cells promote growth and invation of hepatocellular carcinoma and alter the tumor immune microenviroment[D].Fudan University, 2012. (in Chinese) 王志明.大鼠肝星状细胞促进肝癌生长、侵袭及调控免疫微环境的实验研究[D].复旦大学, 2012.

[17]XIA Y, CHEN R, YE S, et al.Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma[J].Clin Exp Metastasis, 2011, 28 (7) :661-674.

[18]OGUNWOBI O, LIU C.Therapeutic and prognostic importance of epithelial-mesenchymal transition in liver cancers:insights from experimental models[J].Crit Rev Oncol Hematol, 2012, 83 (3) :319-328.

[19]GOMIS RR, ALARCON C, NADAL C, et al.C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells[J].Cancer Cell, 2006, 10 (3) :203-214.

[20]CALVISI D, FRAU M, TOMASI M, et al.Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma:novel insights from interspecies comparison[J].Biochim Biophys Acta, 2012, 1826 (1) :215-237.

[21]SOHN B, PARK I, LEE J, et al.Functional switching of TGFbeta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter[J].Gastroenterology, 2010, 138 (5) :1898-1908.

[22]MIKULA M, PROELL V, FISCHER AN, et al.Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-beta dependent fashion[J].J Cell Physiol, 2006, 209 (2) :560-567.

[23]YAN X, CHEN Y.Smad7:not only a regulator, but also a crosstalk mediator of TGF-βsignalling[J].Biochem J, 2011, 434 (1) :1-10.

[24]KESSENBROCK K, PLAKS V, WERB Z.Matrix metalloproteinases:regulators of the tumor microenvironment[J].Cell, 2010, 141 (1) :52-67.

[25]CAPECE D, FISCHIETTI M, VERZELLA D, et al.The inflammatory microenvironment in hepatocellular carcinoma:a pivotal role for tumor-associated macrophages[J].Biomed Res Int, 2013, 2013:187204.

[26]LITTLEPAGE L, STERNLICHT M, ROUGIER N, et al.Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression[J].Cancer Res, 2010, 70 (6) :2224-2234.

[27]LI J, FAN R, ZHAO S, et al.Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells[J].Int J Mol Sci, 2011, 12 (4) :2434-2447.

[28]FORNARI F, MILAZZO M, CHIECO P, et al.In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2[J].J Pathol, 2012, 227 (3) :275-285.

[29]FU B, WU Z, QIN J.Effects of integrins on laminin chemotaxis by hepatocellular carcinoma cells[J].Mol Biol Rep, 2010, 37 (3) :1665-1670.

[30]AUMAILLEY M, BRUCKNER-TUDERMAN L, CARTER W, et al.A simplified laminin nomenclature[J].Matrix Biol, 2005, 24 (5) :326-332.

[31]SANTAMATO A, FRANSVEA E, DITURI F, et al.Hepatic stellate cells stimulate HCC cell migration via laminin-5 production[J].Clin Sci (Lond) , 2011, 121 (4) :159-168.

[32]VAN ZIJL F, ZULEHNER G, PETZ M, et al.Epithelial-mesenchymal transition in hepatocellular carcinoma[J].Future Oncol, 2009, 5 (8) :1169-1179.

[33]SU Y, SHU K, HU C, et al.Hepatic stellate cells attenuate the immune response in renal transplant recipients with chronic hepatitis[J].Transplant Proc, 2012, 44 (3) :725-729.

[34]ZHAO W, SU W, KUANG P, et al.The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma[J].Int J Oncol, 2012, 41 (2) :457-464.

[35]CHINNADURAI R, GRAKOUI A.B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells[J].Hepatology, 2010, 52 (6) :2177-2185.

[36]JIANG Z, CHEN Y, FENG X, et al.Hepatic stellate cells promote immunotolerance following orthotopic liver transplantation in rats via induction of T cell apoptosis and regulation of Th2/Th3-like cell cytokine production[J].Exp Ther Med, 2013, 5 (1) :165-169.

Relative Articles

[1]	Yu ZHANG, Yongfeng YANG. Thinking of the pathological diagnosis of unexplained liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(3): 498-503. doi: 10.3969/j.issn.1001-5256.2023.03.003
[2]	Xixuan WANG, Liangzi DING, Yang CHENG, Hao HAN, Jian YANG, Jiangqiang XIAO, Yi WANG, Ming ZHANG, Feng ZHANG, Yuzheng ZHUGE. Value of liver stiffness measured by acoustic radiation force impulse in diagnosis of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2022, 38(11): 2488-2492. doi: 10.3969/j.issn.1001-5256.2022.11.010
[3]	Jialing ZHOU, Bingqiong WANG, Yameng SUN, Tongtong MENG, Shanshan WU, Hong MA, Xiaojuan OU, Hong YOU, Jidong JIA, Xiaoning WU. Application value of liver stiffness measurement-to-platelet ratio index score in diagnosis of hepatitis B liver fibrosis and liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1529-1533. doi: 10.3969/j.issn.1001-5256.2022.07.014
[4]	Zhongjie YU, Wenxia ZHAO, Leixin FENG, Hanxiao WANG, Jianpeng LIU. Value of five noninvasive diagnostic methods for liver cirrhosis in diagnosis of traditional Chinese medicine syndrome types in patients with compensated hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(1): 104-109. doi: 10.3969/j.issn.1001-5256.2022.01.016
[5]	Yajie XU, Wenzheng YOU, Wanlei REN, Quanhe LONG, Xiangjun JIANG, Doudou HU. Application of pathological indicators based on liver biopsy in the diagnosis of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2021, 37(12): 2935-2938. doi: 10.3969/j.issn.1001-5256.2021.12.042
[6]	Yu WANG, Min WANG, Guanhua ZHANG, Fuliang HE, Xiaojuan OU, Jidong JIA. Clinical diagnosis, staging, and therapeutic principles of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 17-21. doi: 10.3969/j.issn.1001-5256.2021.01.004
[7]	NIU XingJie, LIU ZhiHui, CUI FengMei, LIU YaoMin, WANG YanFei, ZHANG GuoMin, LIU JinXia. Value of peripheral blood long non-coding RNA-LET in the diagnosis of chronic hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(12): 2709-2713. doi: 10.3969/j.issn.1001-5256.2020.12.014
[8]	Zhou ShengYun, Duan ZhiHui. Noninvasive diagnosis of esophageal varices in liver cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(8): 1842-1846. doi: 10.3969/j.issn.1001-5256.2020.08.036
[9]	Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and therapy of hepatic fibrosis(2019)[J]. Journal of Clinical Hepatology, 2019, 35(10): 2163-2172. doi: 10.3969/j.issn.1001-5256.2019.10.007
[10]	Li JiaNa, Zheng RuiQi, Li Na, Hu YuLin. The biological characteristics of GP73 and its value in the diagnosis of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1361-1364. doi: 10.3969/j.issn.1001-5256.2019.06.040
[11]	Zhang YaNan, Jiang Chang, Xu Ying, Gao YanHang. Early diagnosis of spontaneous bacterial peritonitis in liver cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(8): 1851-1853. doi: 10.3969/j.issn.1001-5256.2019.08.045
[12]	Liu HaiFeng, Xu YongSheng, Zhang Yue, Zhao XiaoJu, Liu Zhao, Li JinKui, Yan RuiFeng, Xu Kai, Lei JunQiang. Value of magnetic resonance morphological imaging in the diagnosis and differentiation of post-hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(12): 2587-2591. doi: 10.3969/j.issn.1001-5256.2018.12.016
[13]	Yang ErNa, Cao WuKui. Research advances in noninvasive diagnosis of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2209-2213. doi: 10.3969/j.issn.1001-5256.2017.11.035
[14]	Du JingHua, Nan YueMin. Novel molecular diagnostic markers for liver fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(3): 445-450. doi: 10.3969/j.issn.1001-5256.2017.03.009
[15]	Zhang Hui, Jia Lei, Lu: Dong, Xu YouQing. Value of serum cancer antigen12-5 level in diagnosis of peritoneal effusion in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(11): 2118-2120. doi: 10.3969/j.issn.1001-5256.2016.11.022
[16]	Deng Han, Qi XingShun, Zhu Qiang, Guo XiaoZhong. Alternative methods for diagnosis of esophageal varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(8): 1468-1473. doi: 10.3969/j.issn.1001-5256.2016.08.007
[17]	Zhao Wei. Clinical significance of plasma and urine neutrophil gelatinase-associated lipocalin levels in diagnosis of acute kindney injury in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1874-1877. doi: 10.3969/j.issn.1001-5256.2015.11.025
[18]	Wang Shuai, Hu DaRong. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites[J]. Journal of Clinical Hepatology, 2015, 31(7): 1018-1022. doi: 10.3969/j.issn.1001-5256.2015.07.005
[19]	Cai JunJun, Han Tao. Diagnosis and treatment of acute kidney injury in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1352-1356. doi: 10.3969/j.issn.1001-5256.2014.12.030
[20]	Jia KeDong, Shi ShuXian, Ruan YouBing. Detection of sialic acid in hepatitis involved liver cirrhosis and its significance for HCC diagnosis[J]. Journal of Clinical Hepatology, 2005, 21(2): 101-103.

Supplements(0)

Cited By

Cited by

Periodical cited type(11)

1.	阳丽华，梁英，刘仁峰，刘志昂. 甲状腺癌与甲状腺肿患者相关实验室指标的比较分析. 甘肃医药. 2025(01): 53-55+59 .
2.	张海苗. HBV感染原发性肝癌患者血常规指标的检测意义. 包头医学院学报. 2024(02): 67-71 .
3.	戴倩梅，丁体龙，代雪枫，于莉，陈策. 高敏丙型肝炎病毒核糖核酸在丙型肝炎中的诊断价值. 检验医学与临床. 2024(04): 487-490 .
4.	李晓宇，黄秀香，叶迎宾. 血清壳多糖酶3样蛋白1和PLT的比值与FIB-4指数在慢性乙型肝炎轻、中度诊断效价的比较. 标记免疫分析与临床. 2024(09): 1693-1697 .
5.	何萍，徐瑞，华秋菊，姜璐，王维平. 红细胞分布宽度与血小板比值对终末期肾病维持性血液透析患者动静脉内瘘失功的预测分析. 中国医师进修杂志. 2024(11): 988-994 .
6.	岳丽，孙佳瑶，刘龙芳. 脑小血管病患者外周血GPR30 mRNA、PLR、NPAS4表达及与认知功能、短期预后的关系. 临床误诊误治. 2023(01): 69-74 .
7.	杨杨，刘付弟，曾方林. 人类免疫缺陷病毒/乙型肝炎病毒合并感染者CD4~+T细胞计数和乙型肝炎病毒复制、中性粒细胞与淋巴细胞比值水平的相关性. 中国医药导报. 2023(10): 145-148 .
8.	王跃帮，常珊碧，王梦林，崔倩，裴兵. RLR在HBV相关性肝硬化诊断中的应用. 热带医学杂志. 2023(10): 1451-1455 .
9.	邱建华. PLT联合凝血功能检测对早期肝硬化的诊断价值分析. 现代诊断与治疗. 2023(22): 3433-3435 .
10.	赵霄君，谢建刚，段楚君，刘善收，王倩梅，思艺，王林潇，吴丹，王一帆，李俊杰. 血常规指标与脓毒症患者短期预后的相关性研究. 临床误诊误治. 2022(08): 73-77 .
11.	邵林楠，张树婷，王霓，周世航，刘铭. 血细胞各比值对慢性丙型肝炎病毒患者肝纤维化程度的评估. 临床血液学杂志. 2022(12): 874-877 .

Other cited types(7)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3119) PDF downloads(607)

The role of hepatic stellate cells in development and progression of hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2014.03.023